Abstract:

Operation specification of Mycobacterium tuberculosis recombinant protein skin test (T/CHATA 020—2022), one of the social organization standards issued by the Chinese Antituberculosis association, was put into force since February 24, 2022. The standard specifies the scope of application, contraindications, operating procedures, observation and treatment principles of common adverse reactions, and quality assurance of the Mycobacterium tuberculosis recombinant protein skin test. To help medical staff better understand and normatively apply the Mycobacterium tuberculosis recombinant protein skin test, this article explains the drafting process and major points of the content of this standard.

Key words: Mycobacterium tuberculosis, Infection, Skin tests, Consensus development conferences as topic